OVERSEA CHINESE BANKING Corp Ltd Increases Holdings in Welltower Inc. $WELL

OVERSEA CHINESE BANKING Corp Ltd increased its stake in shares of Welltower Inc. (NYSE:WELL) by 0.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 122,612 shares of the real estate investment trust’s stock after buying an additional 906 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Welltower were worth $18,849,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. SouthState Corp lifted its position in Welltower by 704.8% during the first quarter. SouthState Corp now owns 169 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 148 shares in the last quarter. Wealth Preservation Advisors LLC purchased a new stake in Welltower in the first quarter valued at $27,000. Smallwood Wealth Investment Management LLC purchased a new stake in Welltower in the first quarter valued at $28,000. Hughes Financial Services LLC purchased a new stake in Welltower in the first quarter valued at $31,000. Finally, N.E.W. Advisory Services LLC purchased a new stake in Welltower in the first quarter valued at $32,000. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Wells Fargo & Company lifted their target price on Welltower from $185.00 to $200.00 and gave the company an “overweight” rating in a research report on Tuesday, October 21st. UBS Group assumed coverage on Welltower in a research report on Friday, September 19th. They issued a “buy” rating and a $195.00 target price on the stock. Cantor Fitzgerald assumed coverage on Welltower in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $195.00 target price on the stock. Evercore ISI lifted their target price on Welltower from $175.00 to $183.00 and gave the company an “in-line” rating in a research report on Monday, September 15th. Finally, National Bankshares set a $246.00 target price on Welltower in a research report on Friday, October 17th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $186.43.

Welltower Trading Up 1.1%

Shares of NYSE WELL opened at $178.04 on Monday. Welltower Inc. has a twelve month low of $123.11 and a twelve month high of $180.40. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.44. The stock has a fifty day simple moving average of $170.05 and a 200-day simple moving average of $159.42. The stock has a market capitalization of $119.08 billion, a PE ratio of 100.59, a PEG ratio of 1.99 and a beta of 0.92.

Welltower (NYSE:WELL) last issued its quarterly earnings data on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.06. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The business had revenue of $2.55 billion during the quarter, compared to analysts’ expectations of $2.49 billion. During the same period in the previous year, the firm posted $1.05 earnings per share. The company’s revenue was up 39.6% on a year-over-year basis. On average, equities analysts forecast that Welltower Inc. will post 4.88 earnings per share for the current year.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.